HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Pancras C W Hogendoorn Selected Research

Indicators and Reagents (Reagents)

1/2016Loss of H3K27 tri-methylation is a diagnostic marker for malignant peripheral nerve sheath tumors and an indicator for an inferior survival.
3/2012Presence of chemotherapy-induced toxicity predicts improved survival in patients with localised extremity osteosarcoma treated with doxorubicin and cisplatin: a report from the European Osteosarcoma Intergroup.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Pancras C W Hogendoorn Research Topics

Disease

65Neoplasms (Cancer)
01/2019 - 07/2003
32Osteosarcoma (Osteogenic Sarcoma)
05/2024 - 05/2004
20Chondrosarcoma
04/2013 - 02/2004
18Sarcoma (Soft Tissue Sarcoma)
07/2017 - 08/2005
14Ewing Sarcoma (Sarcoma, Ewing)
01/2017 - 05/2004
10Neoplasm Metastasis (Metastasis)
10/2021 - 08/2005
6Carcinoma (Carcinomatosis)
07/2021 - 01/2011
6Breast Neoplasms (Breast Cancer)
10/2017 - 02/2004
6Paraganglioma (Paragangliomas)
11/2015 - 04/2004
6Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2013 - 08/2005
5Chondroma (Enchondroma)
07/2021 - 03/2004
5Carcinogenesis
11/2012 - 09/2005
5Osteochondroma (Osteocartilaginous Exostosis)
01/2012 - 04/2005
4Fibroma (Fibromatosis)
05/2014 - 06/2005
4Hypoxia (Hypoxemia)
07/2010 - 01/2007
3Genomic Instability
10/2021 - 09/2007
3Osteoblastoma
01/2013 - 01/2010
3Enchondromatosis (Ollier Disease)
09/2005 - 12/2004
2Giant Cell Tumors (Giant Cell Tumor)
09/2022 - 06/2015
2Infections
08/2021 - 10/2016
2Giant Cell Tumor of Bone
01/2019 - 08/2004
2Neurofibrosarcoma (MPNST)
01/2016 - 01/2010
2Pheochromocytoma
11/2015 - 11/2009
2Disease Progression
07/2015 - 04/2010
2Synovial Sarcoma (Synovioma)
08/2014 - 01/2010
2Febrile Neutropenia
04/2014 - 07/2007
2Neutropenia
04/2014 - 07/2007
2Chordoma
11/2012 - 02/2011
2Inflammation (Inflammations)
06/2012 - 04/2003
2Mesenchymal Chondrosarcoma
02/2012 - 03/2008
2Multiple Hereditary Exostoses (Hereditary Multiple Exostoses)
01/2012 - 06/2011
2Myxoid Liposarcoma
12/2010 - 09/2010
2Aneuploidy (Aneuploid)
06/2009 - 07/2003
1Yellow Fever
09/2023

Drug/Important Bio-Agent (IBA)

35Proteins (Proteins, Gene)FDA Link
08/2021 - 03/2004
12Doxorubicin (Adriamycin)FDA LinkGeneric
07/2017 - 01/2007
11Messenger RNA (mRNA)IBA
11/2015 - 11/2005
10DNA (Deoxyribonucleic Acid)IBA
11/2015 - 07/2003
8Transcription Factors (Transcription Factor)IBA
11/2012 - 04/2006
7Biomarkers (Surrogate Marker)IBA
05/2024 - 02/2004
7Phosphotransferases (Kinase)IBA
11/2015 - 08/2009
7Imatinib Mesylate (Gleevec)FDA Link
01/2013 - 08/2005
6IfosfamideFDA LinkGeneric
07/2017 - 07/2007
5ParaffinIBA
05/2024 - 06/2009
5EnzymesIBA
03/2022 - 11/2005
5Histones (Histone)IBA
10/2021 - 06/2012
5Peptides (Polypeptides)IBA
01/2017 - 08/2009
5Cisplatin (Platino)FDA LinkGeneric
10/2016 - 01/2007
4RNA (Ribonucleic Acid)IBA
01/2017 - 05/2009
4Succinate Dehydrogenase (Fumarate Reductase)IBA
11/2015 - 05/2004
4Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA
08/2015 - 08/2009
4ErbB Receptors (EGF Receptor)IBA
01/2012 - 05/2004
4Keratins (Keratin)IBA
07/2011 - 12/2003
3Formaldehyde (Formol)FDA Link
05/2024 - 06/2009
3Chemokine ReceptorsIBA
01/2017 - 04/2003
3Insulin-Like PeptidesIBA
01/2016 - 07/2010
3beta CateninIBA
01/2013 - 09/2005
3Estrogens (Estrogen)FDA Link
07/2011 - 09/2005
3Tyrosine Kinase InhibitorsIBA
01/2011 - 08/2010
3Dasatinib (BMS 354825)FDA Link
09/2010 - 08/2009
3LuciferasesIBA
01/2010 - 02/2007
2InterferonsIBA
05/2024 - 06/2012
2GlycosaminoglycansIBA
11/2019 - 06/2011
2Methotrexate (Mexate)FDA LinkGeneric
10/2016 - 07/2015
2Indicators and Reagents (Reagents)IBA
01/2016 - 03/2012
2ChromatinIBA
01/2016 - 01/2009
2Fumarate Hydratase (Fumarase)IBA
11/2015 - 09/2007
2Small Interfering RNA (siRNA)IBA
11/2015 - 09/2009
2Brachyury protein (Brachyury)IBA
11/2012 - 02/2011
2Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA
01/2012 - 03/2009
2Aromatase (CYP19)IBA
07/2011 - 11/2005
2exemestane (Aromasin)FDA Link
07/2011 - 11/2005
2Mucin-1 (CA 15-3 Antigen)IBA
07/2011 - 06/2010
2Proteoglycans (Proteoglycan)IBA
06/2011 - 03/2011
2GlypicansIBA
06/2011 - 03/2011
2LigandsIBA
04/2011 - 09/2008
2Natural Killer Cell ReceptorsIBA
04/2011 - 09/2008
2Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
02/2011 - 09/2010
2Matrix Metalloproteinases (MMPs)IBA
07/2010 - 04/2010
2Cyclin-Dependent Kinase 4IBA
07/2010 - 07/2006
2Cyclin D1IBA
09/2009 - 09/2005
2Member 1 Subfamily B ATP Binding Cassette TransporterIBA
11/2007 - 10/2006
2Peptide Hydrolases (Proteases)FDA Link
01/2007 - 08/2004
2Estrogen ReceptorsIBA
11/2005 - 02/2004
2OligonucleotidesIBA
12/2004 - 05/2004
2ChemokinesIBA
05/2003 - 04/2003
1Heat-Shock Proteins (Heat-Shock Protein)IBA
05/2024
1CatalaseIBA
05/2024
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2024
1VaccinesIBA
09/2023

Therapy/Procedure

29Therapeutics
06/2022 - 11/2005
27Drug Therapy (Chemotherapy)
05/2024 - 08/2003
8Radiotherapy
10/2017 - 08/2005
4Curettage
07/2021 - 03/2008
3Transplantation
07/2013 - 12/2005
3Adjuvant Chemotherapy
10/2012 - 02/2010
2Immunotherapy
01/2016 - 01/2012
2Bone Transplantation (Bone Grafting)
07/2012 - 01/2011
2Aftercare (After-Treatment)
07/2012 - 09/2010
2Ligation
12/2010 - 03/2007